Lung cancer Doctors in Turkey — Page 2

Dr. Mehmet Dogu Canoglu is a radiation oncologist at Anadolu Medical Center in Istanbul. He specializes in precise tumor targeting using MR Linac and CyberKnife technologies. Dr. Canoglu trained at Kocaeli University. He previously served at Medipol Mega University Hospital. He treats various cancers, including complex brain, prostate, and lung tumors.

• Expert in Varian TrueBeam and Trilogy radiation delivery systems.
• Performs stereotaxic radiosurgery and targeted radiotherapy for sarcomas.
• Works at Anadolu Medical Center, a facility affiliated with Johns Hopkins Medicine.
• Treats patients at a clinic ranked among the world's top 10 for medical tourism.

Dr. Necdet Uskent is a medical oncologist and hematologist at Anadolu Medical Center in Istanbul. He was part of the pioneering team that performed Turkey's first bone marrow transplant. Dr. Uskent holds the European Medical Oncology Certificate and focuses on breast, lung, and gastrointestinal cancers. He works at a facility affiliated with Johns Hopkins Medicine.

• Founder of the Turkish Oncology Group (TOG).
• A founding member of the Turkish Society of Medical Oncology.
• Served as a visiting lecturer at Royal Free and University College Hospital in London.
• Treats complex hematological conditions including lymphomas and myeloma.

Dr Tahsin Ozadli is a dedicated clinical oncologist at Valued Med Hub Hospitals who has performed over 1,100 cancer treatments.

• Specialises in medical oncology at leading Turkish cancer research centres
• Focuses on lung cancer and malignancies of the digestive system
• Trained at the specialist Ankara Oncology Training and Research Hospital
• Maintains an active research profile in clinical oncology outcomes
• Expertise includes managing gastric and oesophageal cancer cases

Professor Ahmet Bilici leads medical oncology at Medipol Mega University Hospital, where he is recognised as a specialist in managing lung cancer and sarcomas.

• Specialises in medical oncology – uses drug-based therapies like chemotherapy and immunotherapy to target tumours
• Serves as a Professor at Medipol Mega – a major JCI-accredited university hospital and research centre
• Expertly reviews complex patient records to design personalised treatment protocols
• Member of the Turkish Medical Oncology Association and internal medicine societies

Professor Ozcan Yildiz is a senior medical oncologist at Medipol Mega University Hospital with a focus on identifying rare presentations of small cell lung cancer.

• Specialises in system-wide drug therapies for both small cell and non-small cell lung cancers
• Published international research on managing thymoma and neuroendocrine tumours involving the chest
• Expert in identifying paraneoplastic syndromes, which are secondary conditions triggered by an immune response to lung cancer
• Focuses on multidisciplinary care for complex metastatic cases requiring systemic intervention

Dr. Mustafa Ondzhel is a professor of oncosurgery and proctology at Medipol Mega University Hospital. He spent five years as a practicing surgeon at the Cleveland Clinic in the USA. Dr. Ondzhel specializes in treating bowel cancer and complex rectal disorders. He is a founder of the Eurasian Colorectal Technologies Association.

• Holds a proctology qualification certificate from the European Commission on Coloproctology.
• Received the Most Successful Scientist of the Year award in the healthcare category.
• Performs Whipple surgery and distal pancreatectomy for gastrointestinal cancers.
• Confirmed as an Official International Fellow of the American Society of Colorectal Surgeons.

Dr Saban Sec is a leading Turkish medical oncologist who specialises in targeted systemic therapies for lung cancer and complex sarcomas. He serves as a representative for the Turkish Medical Oncology Association, helping to shape clinical standards for specialist physicians.

• Focuses on non-small cell lung cancer (NSCLC) management using immune-based and chemotherapeutic protocols
• Conducted research on prognostic markers in lung cancer to help clinicians better predict patient survival
• Expertise includes managing rare tumours and gastrointestinal cancers within a multidisciplinary team
• Active member of the Istanbul Medical Chamber and the Turkish Medical Oncology Association

Professor Turkan Ozturk Topcu is a medical oncology specialist at Valued Med Hub Hospitals who trained at the world-renowned MD Anderson Cancer Center in the USA.

• Specialises in managing lung cancer alongside trachea and bronchial malignancies
• Focuses on targeted protocols for mesothelioma and respiratory system tumours
• Completed international fellowships at Moffitt Cancer Center and Sunnybrook Odette Cancer Center
• Expert in medical oncology, including clinical management of thoracic oncology cases
• Experienced in treating complex cases across internal medicine and oncology clinics

Dr. Yusuf Acikgoz is a medical oncologist at Lokman Hekim University Ankara Hospital. He specializes in treating complex cancers, including lung, breast, and liver malignancies. He completed a fellowship at Ohio State University in the United States. Dr. Acikgoz manages treatments like chemotherapy, radioembolization, and immunotherapy.

• Member of the American Society of Clinical Oncology (ASCO).
• Assistant Investigator for Phase III clinical trials, including the CheckMate-649 study.
• Certified in Good Clinical Practice and Human Subjects Protection at Ohio State University.
• Performs diagnostic procedures like biopsy, gastroscopy, and tumor marker testing.

Professor Didem Tastekin is a leading medical oncologist at Valued Med Hub Hospitals, specialising in lung cancer and innovative therapies like cancer vaccines.

• Trained at the Istanbul University Oncology Institute, a premier centre for specialized cancer research
• Focuses on personalized treatment plans including immunotherapy and targeted drug delivery
• Held senior academic roles at Selçuk University and Atatürk University
• Expertise includes managing rare lung cancers and complex gastrointestinal cases
• Regarded for her work in medical oncology sub-specialist training across Turkey

Professor Gunluoglu is a senior thoracic surgeon at Medipol Mega University Hospital, where he provides specialised surgical reviews for complex respiratory cases.

• Specialises in thoracic surgery focusing on surgical interventions for the chest and lungs
• Provides expert second medical opinions for complex treatment planning
• Member of the Thoracic Surgery Department at a major university teaching hospital
• Collaborates with multidisciplinary oncology teams to refine patient care pathways

The doctor is an oncologist specializing in the treatment of breast, lung, and gastrointestinal cancers. Currently, the doctor practices at Istinye Liv University Hospital.

With a career spanning multiple esteemed institutions, the doctor has served as an Internal Medicine Specialist at Malatya State Hospital, a physician at Ankara Oncology Clinic, and a member of the Oncology Department at Erzurum Regional Training and Research Hospital.

The doctor graduated from the Faculty of Medicine at Selcuk University and achieved the title of Associate Professor in 2016.

Professor Cemil Bilir trained at the Cleveland Clinic and Northeastern University in the US, focusing on pharmaceutical biotechnology to improve drug delivery.

• Specialises in medical oncology for advanced-stage lung cancer management
• Current Professor of Medicine at Sakarya University Faculty of Medicine
• Utilises targeted drug therapies based on his research in pharmaceutical biotechnology
• Maintains international standards as a member of ASCO and ESMO
• Holds a PhD in inorganic chemistry to better understand chemotherapy compositions

Professor Gokhan Haciibrahimoglu is a specialist in thoracic surgical oncology who completed a prestigious fellowship in lung transplantation and vascular surgery at the University of Paris-Sud.

• Performs VATS – keyhole surgery that uses a tiny camera for smaller incisions and faster recovery
• Specialises in complex tracheal and mediastinal surgery for tumours located in the central chest
• Member of the European Society of Thoracic Surgeons
• Authored over 40 papers on respiratory research and surgical outcomes

Associate Professor Tarik Salman brings high-level expertise to lung cancer care, having completed observerships at the world-renowned Memorial Sloan Kettering Cancer Center.

• Specialises in comprehensive genomic profiling to create individual treatment plans
• Uses targeted therapies and immunotherapy to attack specific cancer cells
• Previously served as an academic visitor at the Moffitt Cancer Center in the USA
• Former Board Member of the Turkish Society of Medical Oncology
• Active member of the European Society of Medical Oncology since 2012

Associate Professor Nail Paksoy is a prominent medical oncologist at Medipol Bahçelievler University Hospital with European Board Certification (ESMO). He specialises in managing complex lung cancer cases through targeted therapies and immunotherapy.

• Led clinical trials for Lorlatinib, investigating its effectiveness against specific gene-mutated lung cancers
• Specialises in immunotherapy protocols using Atezolizumab for small cell lung cancer patients
• Expert in treating NSCLC with ALK and ROS1 mutations using targeted drug therapies
• Published research on drug resistance, focusing on why some lung cancers stop responding to treatment
• Member of the European Society for Medical Oncology (ESMO) board

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

• Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
• Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
• Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
• Treats complex oncological cases at the university-affiliated İstinye University clinic.

Dr. Ayşe İrem Yasin is a medical oncologist at Medipol Acıbadem District Hospital in Istanbul. She holds a prestigious ESMO Board Certificate. Dr. Yasin specializes in solid tumors, including breast, lung, and gastrointestinal cancers. She treats complex cases such as Merkel cell carcinoma and cancers of unknown primary.

• Trained at Harvard Medical School, Cleveland Clinic, and Basel University Hospital.
• Completed a clinical observership at the Breast Cancer Unit in Novara, Italy.
• Treats brain and CNS malignancies, soft tissue sarcomas, and urologic cancers.
• Works at a JCI-accredited facility equipped with the da Vinci robotic system.

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.